美国 · SEC FORM 4
Phathom Pharmaceuticals, Inc.
PHAT · Nasdaq · CIK 0001783183 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
12 同一窗口内观察到的 Form 4 交易行
0 sales · 12 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-05-21 · Topper James N.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 10,109,151
- 上期报告
- 10,157,209
- 日均成交量
- 1,373,184
- 回补天数
- 7.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-05-21 | Topper James N | 买入 (P) | Common Stock | 3,780 | USD 3.86 | USD 14,591 | SEC 申报 ↗ |
| 2025-05-14 | Topper James N | 买入 (P) | Common Stock | 6,300 | USD 3.32 | USD 20,916 | SEC 申报 ↗ |
| 2025-05-13 | Topper James N | 买入 (P) | Common Stock | 1,120 | USD 3.16 | USD 3,539 | SEC 申报 ↗ |
| 2025-05-12 | Topper James N | 买入 (P) | Common Stock | 12,601 | USD 3.04 | USD 38,307 | SEC 申报 ↗ |
| 2025-05-09 | Topper James N | 买入 (P) | Common Stock | 35,602 | USD 3.22 | USD 114,528 | SEC 申报 ↗ |
| 2025-05-07 | Parikh Asit | 买入 (P) | Common Stock | 5,000 | USD 2.40 | USD 12,000 | SEC 申报 ↗ |
| 2025-05-06 | Parikh Asit | 买入 (P) | Common Stock | 5,000 | USD 2.60 | USD 13,000 | SEC 申报 ↗ |
| 2025-03-13 | Parikh Asit | 买入 (P) | Common Stock | 10,000 | USD 4.42 | USD 44,200 | SEC 申报 ↗ |
| 2024-12-13 | Parikh Asit | 买入 (P) | Common Stock | 10,000 | USD 8.12 | USD 81,200 | SEC 申报 ↗ |
| 2024-12-13 | KARBE FRANK | 买入 (P) | Common Stock | 12,500 | USD 7.93 | USD 99,125 | SEC 申报 ↗ |
| 2023-11-08 | Parikh Asit | 买入 (P) | Common Stock | 2,500 | USD 7.80 | USD 19,500 | SEC 申报 ↗ |
| 2023-11-07 | Parikh Asit | 买入 (P) | Common Stock | 4,000 | USD 7.76 | USD 31,040 | SEC 申报 ↗ |
| 2023-11-06 | Parikh Asit | 买入 (P) | Common Stock | 1,000 | USD 8.04 | USD 8,040 | SEC 申报 ↗ |
| 2023-04-11 | Nabulsi Azmi | 买入 (P) | Common Stock | 10,000 | USD 8.26 | USD 82,600 | SEC 申报 ↗ |
| 2023-04-10 | Parikh Asit | 买入 (P) | Common Stock | 1,000 | USD 7.55 | USD 7,550 | SEC 申报 ↗ |
Form 4 申报证据
36 transaction lines in the latest 365-day window; 284 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Narula Sanjeev | 代扣税 (F) | Common Stock | 13,485 | USD 6.78 | USD 91,428 | SEC 申报 ↗ |
| 2026-09-03 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 460 | USD 9.05 | USD 4,163 | SEC 申报 ↗ |
| 2026-07-14 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 1,555 | USD 11.04 | USD 17,167 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Narula Sanjeev | 代扣税 (F) | Common Stock | 13,485 | USD 6.78 | USD 91,428 | SEC 申报 ↗ |
| 2026-09-03 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 460 | USD 9.05 | USD 4,163 | SEC 申报 ↗ |
| 2026-07-14 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 1,555 | USD 11.04 | USD 17,167 | SEC 申报 ↗ |
| 2026-05-22 | Parikh Asit | 赠与 (G) | Common Stock | 28,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Parikh Asit | 期权行权／转换 (M) | Common Stock | 17,500 | USD 4.95 | USD 86,625 | SEC 申报 ↗ |
| 2026-05-19 | Topper James N | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Stenhouse Mark | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Schroeder Theodore R | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Parikh Asit | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | KARBE FRANK | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | FIELDS HEIDI | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | COLA MICHAEL F | 奖励／授予 (A) | Common Stock | 24,122 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Parikh Asit | 赠与 (G) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-27 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 1,378 | USD 12.56 | USD 17,308 | SEC 申报 ↗ |
| 2026-02-27 | Breedlove Robert Charles | 奖励／授予 (A) | Common Stock | 15,790 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Cook Anne Marie | 代扣税 (F) | Common Stock | 1,535 | USD 12.82 | USD 19,679 | SEC 申报 ↗ |
| 2026-02-10 | Cook Anne Marie | 奖励／授予 (A) | Common Stock | 3,461 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Basta Steven L | 代扣税 (F) | Common Stock | 6,277 | USD 12.82 | USD 80,471 | SEC 申报 ↗ |
| 2026-02-10 | Basta Steven L | 奖励／授予 (A) | Common Stock | 12,362 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-23 | Parikh Asit | 赠与 (G) | Common Stock | 80,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 776 | USD 13.61 | USD 10,561 | SEC 申报 ↗ |
| 2026-01-13 | Parikh Asit | 期权行权／转换 (M) | Common Stock | 8,750 | USD 10.30 | USD 90,125 | SEC 申报 ↗ |
| 2026-01-02 | Narula Sanjeev | 奖励／授予 (A) | Common Stock | 82,715 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Cook Anne Marie | 奖励／授予 (A) | Common Stock | 75,345 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Basta Steven L | 奖励／授予 (A) | Common Stock | 251,034 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-19 | Parikh Asit | 期权行权／转换 (M) | Common Stock | 8,750 | USD 10.30 | USD 90,125 | SEC 申报 ↗ |
| 2025-12-18 | Breedlove Robert Charles | 代扣税 (F) | Common Stock | 230 | USD 16.28 | USD 3,744 | SEC 申报 ↗ |
| 2025-12-17 | Cook Anne Marie | 代扣税 (F) | Common Stock | 7,703 | USD 15.36 | USD 118,318 | SEC 申报 ↗ |
| 2025-12-17 | Cook Anne Marie | 奖励／授予 (A) | Common Stock | 17,370 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-17 | Basta Steven L | 代扣税 (F) | Common Stock | 31,502 | USD 15.36 | USD 483,871 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PHAT |
| CIK | 0001783183 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 284 transaction lines from 2020-01-04 to 2026-10-06 26 P purchase lines · 166 S sale lines · 92 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.